Mercieca-Bebber Rebecca, Eggins Renee, Brown Kilian, Gebski Val J, Brewer Kate, Lai Lenna, Bailey Lisa, Solomon Michael J, Lumley John W, Hewett Peter, Clouston Andrew D, Wilson Kate, Hague Wendy, Hayes Julian, White Stephen, Morgan Matt, Simes R John, Stevenson Andrew R L
NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
Australasian Gastro-Intestinal Trials Group.
Ann Surg. 2023 Mar 1;277(3):449-455. doi: 10.1097/SLA.0000000000005412. Epub 2022 Feb 15.
The aim of this study was to compare patient-reported urinary, bowel, and sexual functioning of ALaCaRT Trial participants randomized to open or laparoscopic surgery for rectal cancer.
The primary endpoint, noninferiority of laparoscopic surgical resection adequacy, was not established.
Participants completed QLQ-CR29 at baseline, 3, and 12 months post-surgery. Additionally, women completed Rosen's Female Sexual Functioning Index (FSFI). Men completed the International Index of Erectile Function (IIEF) and QLQ-PR25. We compared the proportions of participants in each group who experienced moderate/severe symptoms/dysfunction at each time-point and compared mean difference scores from baseline to 12 months between groups. All analyses were intention-to-treat. Sexual functioning analyses included only the participants who expressed sexual interest at baseline.
Baseline PRO compliance of 475 randomized participants was 88%. At 12 months, a lower proportion of open surgery participants experienced moderate-severe fecal incontinence and sore skin, compared to Laparoscopic participants, and a lower proportion of men randomized to open surgery experienced moderate-severe urinary symptoms. There were no differences at 3 months for bowel or urinary symptoms. Sexual functioning among sexually interested participants was similar between groups at 3 and 12 months; however, a lower proportion of women reported moderate to severe sexual dissatisfaction at 3 months in the open as compared to the laparoscopic group, (Rebecca.mercieca@sydney.edu.au., 95% CI 0.03-0.39).
Despite the slightly lower proportions of open surgery participants self-reporting moderate-severe symptoms for 3 of 16 urinary/bowel domains, and lack of differences in sexual domains, it remains difficult to recommend one surgical approach over another for rectal resection.
本研究旨在比较接受直肠癌开放手术或腹腔镜手术的ALaCaRT试验参与者报告的泌尿、肠道和性功能情况。
主要终点,即腹腔镜手术切除充分性的非劣效性未得到证实。
参与者在基线、术后3个月和12个月完成QLQ-CR29。此外,女性完成罗森女性性功能指数(FSFI)。男性完成国际勃起功能指数(IIEF)和QLQ-PR25。我们比较了每组在每个时间点出现中度/重度症状/功能障碍的参与者比例,并比较了两组从基线到12个月的平均差异得分。所有分析均采用意向性治疗。性功能分析仅包括在基线时表达性兴趣的参与者。
475名随机分组参与者的基线患者报告结局(PRO)依从率为88%。在12个月时,与腹腔镜手术参与者相比,接受开放手术的参与者出现中度至重度大便失禁和皮肤疼痛的比例较低,接受开放手术的男性出现中度至重度泌尿症状的比例也较低。在3个月时,肠道或泌尿症状方面没有差异。在3个月和12个月时,有性兴趣的参与者之间的性功能在两组之间相似;然而,与腹腔镜组相比,接受开放手术的女性在3个月时报告中度至重度性不满的比例较低(Rebecca.mercieca@sydney.edu.au,95%可信区间0.03-0.39)。
尽管接受开放手术的参与者在16个泌尿/肠道领域中的3个领域自我报告中度至重度症状的比例略低,且在性领域方面没有差异,但对于直肠癌切除术,仍然难以推荐一种手术方式优于另一种。